1995-2000

Saunders co-founded Health Care Compliance Association in 1995. He was the chairman of the New York chapter of the American Heart Association. He was on the transition team for New Jersey Governor-elect Chris Christie. In 1997, he was named Compliance Officer of the Year at Health Care Compliance Association. He was the chief compliance officer for Coventry Health Care and for Thomas Jefferson University and Health System. He was senior vice president of Compliance, Legal, and Regulatory at Home Care Corp. of America. He was the chief risk officer of Coventry Health Care from 1998 to 199.

2000-2010

Saunders was a partner and head of the compliance business advisory group at PricewaterhouseCoopers LLP from 2000 to 2003. He joined Schering-Plough from PricewaterhouseCoopers, where he led its compliance business advisory services group. He was a seniorexecutive of Schering-Plough from 2003 to 2010 and its president of Global Consumer Health Care. He was the head of integration for Schering-Plough’s merger with Merck & Co.

2010 to present

Saunders was CEO of Bausch & Lomb from February 2010 to August 2013. While at Bausch & Lomb, he led the company to a sales growth of 9% a year and oversaw the introduction of 34 new products before its acquisition by Valeant Pharmaceuticals in 2013 for $8.7 billion. He was then CEO of Forest Laboratories from October 2013 until its merger with Actavis Plc in 2014, where he stayed as CEO until he acquired Allergan in 2015 and renamed the entire corporation Allergan Plc. He is now chairman, president and CEO of Allergan Plc. He created the “Allergan Social Contract with Patients”, with the stated aim of prohibiting price gouging and offering better patient access to Allergan medicines